Application of the sFlt-1/PlGF Ratio in the Prediction and Management of Preeclampsia: Case Report in a High-Risk Pregnant Woman
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Preeclampsia is one of the leading causes of maternal and perinatal morbidity and mortality.Its diagnosis is based on clinical and paraclinical criteria, although in high-risk patients it can be difficult to identify at early stages.Angiogenic biomarkers, such as the sFlt-1/PlGF ratio, have emerged as highly useful complementary tools.We present the case of a 26-year-old pregnant woman with type 1 diabetes mellitus, who during the course of her pregnancy developed elevated blood pressure values and an increased sFlt-1/PlGF ratio, which guided the diagnosis of preeclampsia without severe features.Serial monitoring of biomarkers allowed close follow-up of disease progression and anticipation of its transition to severe preeclampsia, which prompted termination of pregnancy by cesarean section with favorable neonatal outcomes.The sFlt-1/PlGF ratio is a valuable diagnostic and prognostic tool in preeclampsia, especially in high-risk pregnancies.Its rational use, complemented with clinical assessment and ultrasound, optimizes decision-making and improves maternal and fetal outcomes.josha.org
Fields of Study & Subjects
Pregnancy and preeclampsia studies
Neurological Complications and Syndromes
Pregnancy-related medical research
Publication details
- Journal / source
- Journal of Science Humanities and Arts - JOSHA
- Volume
- 13
- Issue
- 2
- Publication date
- 1 January 2026
- Language
- EN